Feed Articles

Pfizer in the spotlight: How does the pharmaceutical leader face market challenges and what to expect?

DB
David Boulder
· · 2 min read

In recent trading sessions, we've seen interesting developments in shares of pharmaceutical company Pfizer$PFE ).

Pfizer's stock losses over the past month amount to 4.31%, which is in contrast to the 4.24% growth of the medical sector and the S&P 500 index, which gained 4.89%, indicating some challenges Pfizer faces in the market.

However, this leads to the question of whether to buy PFE stock later this year.

Investors are now turning their attention to the company's upcoming earnings, which will be released on January 30, 2024. The company's earnings per share (EPS) is expected to be -0.18 dollars, down 115.7% from the same quarter last year. Revenue is estimated to be $14.3 billion, indicating a decrease of 41.1% compared to the same period last year.

For 2024, Zacks Consensus Estimates expect earnings of $1.53 per share and revenue of $58.67 billion, a shift of -76.75% and -41.53% from a year ago period.

Despite the challenges in the pharmaceutical and medical sectors, Pfizer maintains a solid position. Pfizer ranks in the top 22% of industries with over 250 industries.

Conclusion:

Pfizer stock is currently going through a period of challenges, as indicated by recent losses in value. Although the pharmaceutical giant is facing market pressures, many investors are still keeping a close eye on the company's upcoming results, which will be a key moment for its future direction.

The company's earnings per share and revenue for the final quarter of 2023 are expected to show a significant decline. This data will be important for investors trying to understand how Pfizer is responding to current market challenges and what its potential is going forward.

▪️◾◼️◾▪️

You will find a lot of inspiration on Bulios, but the final stock selection and portfolio construction is of course up to you, so always do a thorough analysis of your own. Thepractical tools within the Bulios Blackmembership are always at your disposal.

Source.

Stocks mentioned

PF

PFE

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more
Oura sells millions of rings a year. Investors will now get a chance to bet on its next growth BLACK

Oura sells millions of rings a year. Investors will now get a chance to bet on its next growth

2d
Read more
3 ETFs on AI Infrastructure BLACK

3 ETFs on AI Infrastructure

Read more
The safest part of your portfolio is taking the biggest hit BLACK

The safest part of your portfolio is taking the biggest hit

2d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.